Insulin dose
1 paper1 finding
- Humans1
Interventions
1Adjunctive therapy
downin humans1
1 study
Adjunctive therapy
downin humans1
Adjunctive therapy decreases insulin dose in humans (0.57 vs 0.64 U/kg/day, p<0.001).
“Patients in the IAT group used lower insulin doses compared with patients from the IO group (0.57 U/kg/day vs 0.64 U/kg/day, p<0.001).”
Humansin autoimmune diabetes (RENACED-DT1 registry)
SAT-604 Use of Adjunctive Therapy in Patients With Autoimmune Diabetes In the Renaced DT1 Registry
ENDO 2025 abstract22 Oct 2025
Latest
17 in 12 monthsFrontiers in Endocrinology
Liraglutide use in congenital generalized lipodystrophy: glycemic and metabolic outcomes
Case series of 8 peopleLiraglutide
Diabetes Technology & Therapeutics
Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review
ReviewType 1 diabetes
Acta Diabetologica
Effects of dapagliflozin on proteinuria, glycemic control, and treatment burden in diabetic kidney transplant recipients: a matched cohort study
Cohort study of 30 peopleDapagliflozin
Federal Practitioner
Efficacy of Subcutaneous Semaglutide Dose Escalation in Reducing Insulin in Patients With Type 2 Diabetes
Cohort study of 62 peopleSemaglutide
Diabetes Research and Clinical Practice
Physical and psychosocial complications faced by postmenopausal women with type 1 diabetes: a cross-sectional BETTER analysis
Cross-sectional study of 211 peopleType 1 diabetes
Preprints.org
Real-World Insulin Deintensification and Discontinuation with GLP-1 Incretin Therapies Versus SGLT2 Inhibitors in Type 2 Diabetes
Preprint: cohort study of 1,029 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Glucagon-like Peptide 1 Receptor Agonist Use in Youth with Type 1 Diabetes Mellitus at an Academic Pediatric Medical Center
Cohort study of 18 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Semaglutide Use Along with Neural Network Fully Closed-Loop Systems Improves Time in Range (TIR) to 87% in Adults with Type 1 diabetes: In Silico Study
Computational studySemaglutide
ADA Scientific Sessions 2026 Abstract
Impact and Effectiveness of Once-Weekly Semaglutide in Achieving Glycemic Targets among Public Health Care Patients with Type 2 Diabetes in Chile: A Multicenter Prospective Study
Non-randomised trial in 104 peopleSemaglutide